{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-community-engagement-requirements-in-lmic-contexts”
},
“headline”: “SOP for Community Engagement Requirements in LMIC Contexts”,
“description”: “This SOP outlines standardized procedures for community engagement in clinical trials conducted in low- and middle-income countries (LMICs). It ensures compliance with WHO expectations, ethical standards, and cultural sensitivity while fostering trust and transparency with trial communities.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}
Published on 26/12/2025
Standard Operating Procedure for Community Engagement Requirements in LMIC Contexts
| SOP No. | CR/OPS/151/2025 |
| Supersedes | NA |
| Page No. | X of Y |
| Issue Date | 26/08/2025 |
| Effective Date | 01/09/2025 |
| Review Date | 01/09/2026 |
Purpose
The purpose of this SOP is to define structured community engagement practices for clinical trials conducted in low- and middle-income countries
Scope
This SOP applies to sponsors, CROs, investigators, community advisory boards (CABs), and ethics committees involved in trials in LMICs. It covers strategies for communication, cultural adaptation, engagement activities, and documentation of community interactions.
Responsibilities
- Sponsor: Ensures trial design includes adequate provisions for community engagement.
- CRO: Coordinates and documents engagement activities at site and community level.
- Investigator: Engages local communities, addresses concerns, and maintains records.
- Community Advisory Boards (CAB): Provides feedback and supports trial acceptability in the local context.
- EC: Reviews engagement strategies as part of ethical approval process.
Accountability
The Principal Investigator (PI) is accountable for ensuring community engagement activities are culturally appropriate, documented, and aligned with WHO ethical guidelines.
Procedure
1. Community Mapping
1.1 Identify relevant community stakeholders (leaders, health workers, NGOs).
1.2 Conduct baseline cultural and literacy assessment.
1.3 Record in Community Mapping Log (Annexure-1).
2. Engagement Planning
2.1 Develop a Community Engagement Plan (CEP) tailored to local context.
2.2 Translate key trial information into local languages.
2.3 Document plan in Engagement Planning Log (Annexure-2).
3. Engagement Activities
3.1 Conduct informational meetings, workshops, and Q&A sessions.
3.2 Establish community advisory boards.
3.3 Document activities in Engagement Activity Log (Annexure-3).
4. Feedback and Grievance Mechanisms
4.1 Implement community feedback systems (meetings, hotlines).
4.2 Record in Feedback and Grievance Log (Annexure-4).
5. Monitoring and Reporting
5.1 Monitor engagement effectiveness using surveys and attendance records.
5.2 Report engagement outcomes to EC and sponsor.
5.3 Document in Monitoring and Reporting Log (Annexure-5).
Abbreviations
- SOP: Standard Operating Procedure
- LMIC: Low- and Middle-Income Countries
- WHO: World Health Organization
- CRO: Contract Research Organization
- EC: Ethics Committee
- PI: Principal Investigator
- CAB: Community Advisory Board
Documents
- Community Mapping Log (Annexure-1)
- Engagement Planning Log (Annexure-2)
- Engagement Activity Log (Annexure-3)
- Feedback and Grievance Log (Annexure-4)
- Monitoring and Reporting Log (Annexure-5)
References
- WHO – Clinical Trials Registry Platform
- WHO – Standards and Operational Guidance for Ethics Review of Health-Related Research with Human Participants
- ICMR – National Ethical Guidelines
Version: 1.0
Approval Section
| Prepared By | Ravi Kumar, Community Engagement Coordinator |
| Checked By | Sunita Reddy, QA Officer |
| Approved By | Dr. Anil Sharma, Principal Investigator |
Annexures
Annexure-1: Community Mapping Log
| Date | Community | Stakeholders Identified | Verified By | Status |
|---|---|---|---|---|
| 01/09/2025 | Village A | Leaders, Health Workers | CRO | Completed |
Annexure-2: Engagement Planning Log
| Date | Protocol ID | Plan Developed By | Status |
|---|---|---|---|
| 02/09/2025 | CTA-2025-05 | Engagement Officer | Approved |
Annexure-3: Engagement Activity Log
| Date | Activity | Community | Conducted By | Status |
|---|---|---|---|---|
| 05/09/2025 | Community Meeting | Village A | Investigator | Completed |
Annexure-4: Feedback and Grievance Log
| Date | Community | Feedback/Grievance | Action Taken | Status |
|---|---|---|---|---|
| 07/09/2025 | Village A | Concerns about safety | Addressed in follow-up meeting | Resolved |
Annexure-5: Monitoring and Reporting Log
| Date | Protocol ID | Monitoring Activity | Reported By | Status |
|---|---|---|---|---|
| 10/09/2025 | CTA-2025-05 | Survey Feedback | CRO | Reported |
Revision History
| Revision Date | Revision No. | Revision Details | Reason for Revision | Approved By |
|---|---|---|---|---|
| 26/08/2025 | 00 | Initial version | New SOP creation | Principal Investigator |
For more SOPs visit: Pharma SOP